Baidu
map

Lower-dose decitabine improves clinical response compared with best supportive care in lower-risk MDS patients: a prospective, multicenter phase 2 study

Ye, L; Mei, C; Ren, YL; Zhou, XP; Ma, LY; Xu, WL; Wei, JY; Jiang, HF; Zhang, LM; Zeng, H; Tong, HY

Tong, HY (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Hematol, 79 Qingchun Rd, Hangzhou 310003, Zhejiang, Peoples R China.

JOURNAL OF CANCER, 2021; 12 (10): 2975

Abstract

Purpose: To explore the efficacy and safety of lower-dose decitabine in patients with lower-risk MDS, a prospective multicenter phase II study was con......

Full Text Link


Baidu
map
Baidu
map
Baidu
map